FAM maleimide, 6-isomer
| Cat. # | Quantity | Price | Lead time | Buy this product |
|---|---|---|---|---|
| 24180 | 5 mg | – | in stock | |
| 44180 | 25 mg | $260 | in stock | |
| 54180 | 50 mg | $370 | in stock | |
| 64180 | 100 mg |
$525
|
in stock |
FAM (fluorescein) is a bright fluorophore which is compatible with various fluorescence detection instruments. FAM is a universal dye that is useful for microscopy, qPCR and many other methods as well as for FRET-based and fluorescence polarization based binding assays.
FAM maleimide is a thiol reactive dye for the labeling of proteins, peptides, and other thiolated molecules.
FAM absorbance and emission spectra
Recommended protocol
Calculator
Customers also purchased with this product
BDP® 493/503 lipid stain
BDP 493/503 is a lipophilic green fluorescent dye for the staining and tracing of cell membranes, lipids, and oils.AF 430 maleimide
AF 430 is a green-yellow emitting fluorescent dye of the coumarin series. This maleimide derivative allows the labeling of thiolated biomolecules.ROX maleimide, 5-isomer
ROX maleimide is a thiol reactive dye derivative based on isomerically bright rhodamine X fluorophore.General properties
| Appearance: | yellow solid |
| Mass spec M+ increment: | 498.4 |
| Molecular weight: | 498.44 |
| Molecular formula: | C27H18N2O8 |
| Solubility: | good in DMSO, DMF |
| Quality control: | NMR 1H, HPLC-MS (95%) |
| Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
| MSDS: | Download |
| Product specifications |
Spectral properties
| Excitation/absorption maximum, nm: | 492 |
| ε, L⋅mol−1⋅cm−1: | 74000 |
| Emission maximum, nm: | 517 |
| Fluorescence quantum yield: | 0.93 |
| CF260: | 0.22 |
| CF280: | 0.17 |
Product citations
- Huang, S.; Gao, Y.; Ma, L.; Jia, B.; Zhao, W.; Yao, Y.; Li, W.; Lin, T.; Wang, R.; Song, J.; Zhang, W. Design of pH-responsive antimicrobial peptide melittin analog-camptothecin conjugates for tumor therapy. Asian Journal of Pharmaceutical Sciences, 2024, 19(1), 100890. doi: 10.1016/j.ajps.2024.100890
- Peterson, B. G.; Hwang, J.; Russ, J. E.; Schroeder, J. W.; Freddolino, P. L.; Baldridge, R. D. Deep Mutational Scanning Highlights a Role for Cytosolic Regions in Hrd1 Function. Cell Reports, 2023, 42(11), 113451. doi: 10.1016/j.celrep.2023.113451
- Kalinovsky, D. V.; Kholodenko, I. V.; Kibardin, A. V.; Doronin, I. I.; Svirshchevskaya, E. V.; Ryazantsev, D. Y.; Konovalova, M. V.; Rozov, F. N.; Larin, S. S.; Deyev, S. M.; Kholodenko, R. V. Minibody-Based and ScFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells. International Journal of Molecular Sciences, 2023, 24(2), 1239. doi: 10.3390/ijms24021239
- Visentin, A.; Demitroff, N.; Salgueiro, M.; Borkosky, S. S.; Uversky, V. N.; Camporeale, G.; de Prat-Gay, G. Assembly of the Tripartite and RNA Condensates of the Respiratory Syncytial Virus Factory Proteins In Vitro: Role of the Transcription Antiterminator M2-1. Viruses, 2023, 15(6), 1329. doi: 10.3390/v15061329
The count of items is incorrect.
Your cart is empty
$ 
